69 related articles for article (PubMed ID: 2187485)
41. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.
Kräusslich HG; Ingraham RH; Skoog MT; Wimmer E; Pallai PV; Carter CA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):807-11. PubMed ID: 2644644
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of the aspartic proteinase from HIV-2.
Richards AD; Broadhurst AV; Ritchie AJ; Dunn BM; Kay J
FEBS Lett; 1989 Aug; 253(1-2):214-6. PubMed ID: 2668032
[TBL] [Abstract][Full Text] [Related]
43. Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease.
Rich DH; Green J; Toth MV; Marshall GR; Kent SB
J Med Chem; 1990 May; 33(5):1285-8. PubMed ID: 2184237
[No Abstract] [Full Text] [Related]
44. Expression of simian immunodeficiency virus (SIVmac) proteinase in E. coli.
Sugrue RJ; Wilderspin AF
Biochem Soc Trans; 1992 May; 20(2):161S. PubMed ID: 1327907
[No Abstract] [Full Text] [Related]
45. Alteration of the Kinetic Properties of an Enzyme by the Binding of Buffer, Inhibitor, or Substrate.
Alberty RA; Bock RM
Proc Natl Acad Sci U S A; 1953 Sep; 39(9):895-900. PubMed ID: 16589350
[No Abstract] [Full Text] [Related]
46. The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation.
Lyonnais S; Sadiq SK; Lorca-Oró C; Dufau L; Nieto-Marquez S; Escribà T; Gabrielli N; Tan X; Ouizougun-Oubari M; Okoronkwo J; Reboud-Ravaux M; Gatell JM; Marquet R; Paillart JC; Meyerhans A; Tisné C; Gorelick RJ; Mirambeau G
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835118
[TBL] [Abstract][Full Text] [Related]
47. HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.
Mirambeau G; Lyonnais S; Coulaud D; Hameau L; Lafosse S; Jeusset J; Borde I; Reboud-Ravaux M; Restle T; Gorelick RJ; Le Cam E
PLoS One; 2007 Aug; 2(7):e669. PubMed ID: 17712401
[TBL] [Abstract][Full Text] [Related]
48. A yeast-based growth assay for the analysis of site-specific proteases.
Köhler F
Nucleic Acids Res; 2003 Feb; 31(4):e16. PubMed ID: 12582261
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the protease of a fish retrovirus, walleye dermal sarcoma virus.
Fodor SK; Vogt VM
J Virol; 2002 May; 76(9):4341-9. PubMed ID: 11932400
[TBL] [Abstract][Full Text] [Related]
50. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.
Louis JM; Nashed NT; Parris KD; Kimmel AR; Jerina DM
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7970-4. PubMed ID: 8058744
[TBL] [Abstract][Full Text] [Related]
51. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.
Billich A; Hammerschmid F; Peichl P; Wenger R; Zenke G; Quesniaux V; Rosenwirth B
J Virol; 1995 Apr; 69(4):2451-61. PubMed ID: 7884893
[TBL] [Abstract][Full Text] [Related]
52. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.
Rosenwirth B; Billich A; Datema R; Donatsch P; Hammerschmid F; Harrison R; Hiestand P; Jaksche H; Mayer P; Peichl P
Antimicrob Agents Chemother; 1994 Aug; 38(8):1763-72. PubMed ID: 7527198
[TBL] [Abstract][Full Text] [Related]
54. SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety.
Billich A; Fricker G; Müller I; Donatsch P; Ettmayer P; Gstach H; Lehr P; Peichl P; Scholz D; Rosenwirth B
Antimicrob Agents Chemother; 1995 Jul; 39(7):1406-13. PubMed ID: 7492076
[TBL] [Abstract][Full Text] [Related]
55. beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.
Baum EZ; Bebernitz GA; Gluzman Y
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):10023-7. PubMed ID: 2124694
[TBL] [Abstract][Full Text] [Related]
56. A genetic system for studying the activity of a proteolytic enzyme.
Dasmahapatra B; DiDomenico B; Dwyer S; Ma J; Sadowski I; Schwartz J
Proc Natl Acad Sci U S A; 1992 May; 89(9):4159-62. PubMed ID: 1570342
[TBL] [Abstract][Full Text] [Related]
57. Purification, assay and kinetic features of HIV-1 proteinase.
Billich A; Hammerschmid F; Winkler G
Biol Chem Hoppe Seyler; 1990 Mar; 371(3):265-72. PubMed ID: 2187485
[TBL] [Abstract][Full Text] [Related]
58. Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.
Strickler JE; Gorniak J; Dayton B; Meek T; Moore M; Magaard V; Malinowski J; Debouck C
Proteins; 1989; 6(2):139-54. PubMed ID: 2695927
[TBL] [Abstract][Full Text] [Related]
59. Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose.
Rittenhouse J; Turon MC; Helfrich RJ; Albrecht KS; Weigl D; Simmer RL; Mordini F; Erickson J; Kohlbrenner WE
Biochem Biophys Res Commun; 1990 Aug; 171(1):60-6. PubMed ID: 2203350
[TBL] [Abstract][Full Text] [Related]
60. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
